Clincosm LogoSign in Get a demo

hepatitis b, chronic

Showing 1 - 25 of 226
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatitis B, Chronic Trial in Jilin (AHB-137 injection, Placebo)

Recruiting
  • Hepatitis B, Chronic
  • AHB-137 injection
  • Placebo
  • Jilin, China
    The First Hospital of Jilin University
Nov 2, 2023

Predict Antiviral Therapy in Gray Zone of Chronic Hepatitis B

Not yet recruiting
  • Hepatitis B, Chronic
  • Exposure factors
  • (no location specified)
Sep 10, 2023

Fibronectin Type ? Domain Containing Protein 5 \ Irsin Gene

Recruiting
  • Hepatitis B, Chronic
  • genotyping
  • Sohag, Egypt
    Sohag university Hospital
Sep 4, 2023

Hepatitis B, Chronic Trial in Seoul (Vemliver tablet, Entecavir Tablet)

Recruiting
  • Hepatitis B, Chronic
  • Vemliver tablet
  • Entecavir Tablet
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Aug 17, 2023

HBsAg Declined Patients Follow-up Study

Not yet recruiting
  • Hepatitis B
  • Hepatitis B, Chronic
    • (no location specified)
    Jul 28, 2023

    Real-world Study Optimizing Nucleotide-analogues

    Recruiting
    • Hepatitis B, Chronic
    • Hefei, Anhui, China
    • +43 more
    Jul 7, 2023

    Hepatitis B, Chronic Trial in Hefei (PEGylated recombinant human interferon alpha-2b injection)

    Recruiting
    • Hepatitis B, Chronic
    • PEGylated recombinant human interferon alpha-2b injection
    • Hefei, Anhui, China
      The First Affiliated Hospital of Anhui Medical University
    Jun 24, 2023

    Population in Improving Eearly Diagnosis Efficancy in Chinese

    Recruiting
    • Carcinoma, Hepatocellular
    • +4 more
    • Liver cancer surveillance every 3 months
    • +2 more
    • Shanghai, Shanghai, China
      Department of Infectious Diseases , Ruijin Hospital, Shanghai Ji
    May 13, 2023

    Hepatitis B, Chronic Trial in Worldwide (IMC-I109V-101 Single Ascending Dose, IMC-I109V-101 Multiple Ascending Doses)

    Recruiting
    • Hepatitis B, Chronic
    • IMC-I109V-101 Single Ascending Dose
    • IMC-I109V-101 Multiple Ascending Doses
    • Los Angeles, California
    • +19 more
    May 10, 2023

    Treatment Optimization of Refractory

    Recruiting
    • Hepatitis B, Chronic
    • Virus Diseases
    • original therapy
    • rescue therapy
    • Ankang, China
    • +12 more
    Feb 1, 2023

    Chronic Hepatitis B:Multicenter Retrospective Cohort Study

    Recruiting
    • Hepatitis B, Chronic
      • Amsterdam, Netherlands
      • +2 more
      Jan 23, 2023

      Hepatitis B, Chronic Trial in Worldwide (GSK3228836, GSK3528869A, Control)

      Recruiting
      • Hepatitis B, Chronic
      • Edegem, Belgium
      • +47 more
      Jan 24, 2023

      Hepatitis B, Chronic Trial in Worldwide (JNJ-73763989, PD-1 inhibitor, Tenofovir Disoproxil)

      Recruiting
      • Hepatitis B, Chronic
      • Vancouver, British Columbia, Canada
      • +31 more
      Jan 17, 2023

      Hepatitis B, Chronic Trial in Worldwide (JNJ-73763989, JNJ-64300535, ETV monohydrate)

      Active, not recruiting
      • Hepatitis B, Chronic
      • Edegem, Belgium
      • +12 more
      Jan 17, 2023

      Hepatitis B, Chronic Trial in Worldwide (JNJ-73763989, PegIFN-alpha-2a, Tenofovir disoproxil)

      Terminated
      • Hepatitis B, Chronic
      • Hillsborough, New Jersey
      • +11 more
      Dec 28, 2022

      Hepatitis B, Chronic Trial in Auckland (VIR-3434, VIR-2218, TDF)

      Recruiting
      • Hepatitis B, Chronic
      • Auckland, New Zealand
      • +1 more
      Dec 19, 2022

      Hepatitis B, Chronic, Hepatitis D Trial in Chisinau, Kyiv (ATI-2173, Viread, AB-729)

      Terminated
      • Hepatitis B, Chronic
      • Hepatitis D
      • Chisinau, Republic Of Moldova, Moldova, Republic of
      • +1 more
      Nov 15, 2022

      Hepatitis B, Chronic Trial in Worldwide (peginterferon alfa-2a [Pegasys])

      Completed
      Has Results
      • Hepatitis B, Chronic
      • peginterferon alfa-2a [Pegasys]
      • San Francisco, California
      • +38 more
      Oct 26, 2022

      Thrombocytopenia, Hepatitis B, Chronic, Acute-On-Chronic Liver Failure Trial in Guangzhou (Avatrombopag, Artificial Liver

      Recruiting
      • Thrombocytopenia
      • +2 more
      • Guangzhou, Guangdong, China
        Third Affiliated Hospital of Sun Yat-sen University
      Nov 8, 2022

      Hepatitis B, Chronic Trial in Toronto (Tenofovir disoproxil fumarate)

      Active, not recruiting
      • Hepatitis B, Chronic
      • Tenofovir disoproxil fumarate
      • Toronto, Ontario, Canada
        University Health Network - Toronto General Hospital
      Nov 1, 2022

      Hepatitis B, Chronic Trial in Worldwide (Entecavir (ETV), Tenofovir Disoproxil Fumarate (TDF), Tenofovir Alafenamide (TAF))

      Withdrawn
      • Hepatitis B, Chronic
      • Entecavir (ETV)
      • +2 more
      • Kolding, Denmark
      • +29 more
      Oct 27, 2022

      Hepatitis B, Chronic Trial in Worldwide (VIR-2218, VIR-3434, PEG-IFNa)

      Recruiting
      • Hepatitis B, Chronic
      • San Francisco, California
      • +39 more
      Oct 3, 2022

      Hepatitis B, Chronic Trial in Worldwide (DCR-HBVS, Placebo for DCR-HBVS)

      Completed
      • Hepatitis B, Chronic
      • Clayton, Victoria, Australia
      • +8 more
      Sep 28, 2022

      Hepatitis B, Hepatitis B, Chronic Trial in Bamenda

      Active, not recruiting
      • Hepatitis B
      • Hepatitis B, Chronic
        • Bamenda, Northwest, Cameroon
          Mbingo Baptist Hospital
        Sep 13, 2022

        Healthy, Hepatitis B, Chronic Trial in Grafton (JNJ-64457744, Placebo, Tenofovir Disoproxil Fumarate (TDF))

        Recruiting
        • Healthy
        • Hepatitis B, Chronic
        • Grafton, New Zealand
          New Zealand Clinical Research
        Aug 11, 2022